Trimetrexate in prostatic cancer: preliminary observations on the use of prostate-specific antigen and acid phosphatase as a marker in measurable hormone-refractory disease.
暂无分享,去创建一个
N. Geller | H. Scher | D. Dershaw | T. Curley | S. Y. Lin | J. Nisselbaum | C. Engstrom | K. Fitzpatrick | M. Schwartz | L. Bezirdjian